Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Belle Health vs Coby Health

Belle Health
Graded #48

Higher grade

vs+11
Coby Health
Graded #211

Lower grade

The verdict

Belle Health takes it — 77/100 to 66/100.

Belle Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Belle Health is a national DTC telehealth platform offering compounded semaglutide and tirzepatide with flat-rate pricing — the same monthly cost at every dose, with no escalation surcharge as you titrate up.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBelle Health +28
92
64
Dose & formulationBelle Health +18
72
54
Clinical oversightCoby Health +10
71
81
Labs & monitoringBelle Health +17
72
55
FulfillmentCoby Health +1
85
86
Contract termsEven
55
55
Belle Health · left barCoby Health · right bar

The numbers

MetricBelle HealthCoby Health
WeighScore77/10066/100
GradeC+C
Scorecard rank#48#211
Semaglutide$119/mo$159/mo (0.25 mg dose, compounded)
Tirzepatide$199/mo (all doses, 3-month plan, compounded)$239/mo (2.5 mg dose, compounded)
CoverageAll 50 states46 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Belle Health

Graded #48 · C+

Strengths

  • Five named compounding pharmacy partners disclosed (Striker, Strive, OptioRx, Enovex, Braun PharmaCare)
  • Flat-rate pricing — $119/mo semaglutide, $199/mo tirzepatide — doesn't rise at higher doses
  • Free weekly registered-dietitian sessions included
  • Operating since 2017
  • LegitScript Certified

Where it loses points

  • $199 tirzepatide price requires a 3-month bundle commitment
  • Compounded medications are not FDA-approved
  • Multi-pharmacy model — formulations may differ across orders
  • FDA issued this company a warning letter dated 20 February 2026; the letter is public in FDA's warning-letter database
Coby Health

Graded #211 · C

Strengths

  • LegitScript Certified (seal 38387067)
  • No membership fee
  • Aggressive 6-month bundle pricing
  • Beluga Health P.A. clinical network — board-certified, 50-state licensure
  • Trustpilot 4.9/5 (~83 reviews)

Where it loses points

  • Does NOT publicly name compounding pharmacy partner(s) — transparency gap vs Belle/Joi+Blokes
  • Compounded medications are not FDA-approved
  • Tirzepatide pricing escalates steeply ($439/mo at 15mg monthly)
  • $50 non-refundable cancellation fee
  • No oral GLP-1 options

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard